Search

AxoGen Inc

Geschlossen

BrancheGesundheitswesen

41.79 -0.14

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

41.61

Max

42.51

Schlüsselkennzahlen

By Trading Economics

Einkommen

18M

-1.5M

Verkäufe

8.3M

70M

EPS

-0.03

Gewinnspanne

-2.174

Angestellte

622

EBITDA

15M

-2.2M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+30.16% upside

Dividenden

By Acuity

Nächstes Ergebnis

28. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

408M

2.6B

Vorheriger Eröffnungskurs

41.93

Vorheriger Schlusskurs

41.79

Nachrichtenstimmung

By Acuity

50%

50%

126 / 339 Ranking in Healthcare

AxoGen Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Sept. 2026, 20:13 UTC

AxoGen Inc shares are lower in after-market hours with no specific news identified. Recent inflation data has raised speculation about a Federal Reserve rate hike.

10. Sept. 2026, 20:03 UTC

News
Social Media
Event

AxoGen Inc shares are lower after announcing a public offering of 4.91 million shares at $42.50 to fund its $200 million acquisition of BioCircuit Technologies.

8. Sept. 2026, 20:07 UTC

News

AxoGen Inc shares are lower today, continuing a downward trend amid speculation of an interest rate hike following a stronger-than-expected jobs report.

3. Sept. 2026, 19:56 UTC

AxoGen Inc shares are lower, extending a five-session decline amid broader market dynamics and a drop in Treasury yields following jobless claims data.

2. Sept. 2026, 20:01 UTC

AxoGen Inc shares are lower today, marking four consecutive sessions of declines. Broader market sentiment is affected by a disappointing ADP employment report.

1. Sept. 2026, 20:09 UTC

News

AxoGen Inc shares are lower today, continuing a decline since Monday amid rising oil prices and inflation concerns affecting the health care equipment sector.

31. Aug. 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting positive momentum despite no specific company news. Broader market sentiment is influenced by Fed Chair Warsh's remarks.

28. Aug. 2026, 23:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting positive momentum. The stock is near the upper end of its one-month trading range.

27. Aug. 2026, 19:56 UTC

News

AxoGen shares are higher as Bamco Inc. acquired 740,210 shares valued at $34.19 million in the second quarter, boosting institutional sentiment.

26. Aug. 2026, 23:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting broader market trends and positive macroeconomic data indicating underlying economic strength.

25. Aug. 2026, 19:46 UTC

AxoGen Inc shares are higher during Tuesday's session, reflecting upward momentum amid broader positive trends in equities and a favorable health care equipment sector.

24. Aug. 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, maintaining gains since Monday's close and positioned near the upper end of their one-month range.

21. Aug. 2026, 20:01 UTC

AxoGen Inc shares are higher today, supported by high trading volume. The stock remains above its 20-day moving average amid broader market gains.

20. Aug. 2026, 22:46 UTC

AxoGen Inc shares are higher in after-market trading, showing notable strength above the 20-day moving average and near the upper end of its one-month range.

19. Aug. 2026, 21:01 UTC

AxoGen Inc shares are lower in after-market trading, despite no specific news to explain the decline. The stock remains near its one-month high.

18. Aug. 2026, 19:16 UTC

AxoGen Inc shares are higher, continuing positive momentum from Monday. The stock remains above its 20-day moving average, reflecting strong performance.

17. Aug. 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reaching a peak above Monday's close amid broader market pressures and rising crude oil prices.

14. Aug. 2026, 20:06 UTC

AxoGen Inc's shares are higher today amid mixed market sentiment following a decline in U.S. retail sales for July. No specific company news was identified.

13. Aug. 2026, 22:36 UTC

AxoGen Inc. shares declined in after-market trading, despite broader market strength and earlier gains. The stock remains above recent performance averages.

12. Aug. 2026, 19:32 UTC

AxoGen Inc shares are higher today amid strong trading volume and broader market gains, reflecting optimism from recent inflation data.

10. Aug. 2026, 19:41 UTC

AxoGen Inc shares are higher, driven by gains in the Health Care Equipment sub-sector and unusually high market volume. The stock remains above its 20-day moving average.

7. Aug. 2026, 20:05 UTC

AxoGen Inc shares are higher today amid strong market volume, reflecting a broader upward trend since Thursday's close.

5. Aug. 2026, 19:46 UTC

AxoGen Inc shares are lower amid broader market caution following ADP's report of a significant miss in private sector job growth for July.

4. Aug. 2026, 20:06 UTC

AxoGen Inc's shares are higher today, continuing a steady climb since Monday's close amid positive market sentiment and broader trends.

3. Aug. 2026, 20:02 UTC

News

AxoGen Inc. shares are advancing as trading volume spikes amid strong interest. The company reported a 23.1% revenue increase to $69.7 million for Q2 2026.

31. Juli 2026, 20:06 UTC

AxoGen Inc shares are higher, recovering from an earlier dip. The stock remains above its 20-day moving average, reflecting solid overall performance.

30. Juli 2026, 19:24 UTC

AxoGen Inc shares are higher, supported by significant broader market gains and unusually high trading volume, despite earlier pulling back from session highs.

29. Juli 2026, 20:41 UTC

AxoGen Inc shares are lower in after-market trading amid a broader downturn in U.S. equities and rising crude oil prices linked to geopolitical tensions.

28. Juli 2026, 20:03 UTC

AxoGen Inc. shares are declining today, pulling back from an earlier high amid broader market weakness linked to declines in Asian indices.

27. Juli 2026, 19:16 UTC

AxoGen Inc shares are higher today, continuing a strong upward trend since Friday's close. Broader market sentiment is influenced by declining oil prices.

Peer-Vergleich

Kursveränderung

AxoGen Inc Prognose

Kursziel

By TipRanks

30.16% Vorteil

12-Monats-Prognose

Durchschnitt 54.875 USD  30.16%

Hoch 60 USD

Tief 48 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AxoGen Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

8

Buy

0

Halten

0

Sell

Stimmung

By Acuity

126 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
help-icon Live chat